Guardalben, Emanuele, Medical Affairs, Roche S.p.A., Monza, Italy, Italy

• Vol 23, No 1 (2022) - Original research
  Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis
  Abstract  HTML  PDF